Shield Therapeutics plc (AIM: STX)
4.850
-0.250 (-4.90%)
Sep 10, 2024, 4:27 PM GMT+1
Shield Therapeutics Revenue
Shield Therapeutics had revenue of $12.13M USD in the half year ending June 30, 2024, with 364.12% growth. This brings the company's revenue in the last twelve months to $21.47M, up 223.99% year-over-year. In the year 2023, Shield Therapeutics had annual revenue of $13.09M with 137.95% growth.
Revenue (ttm)
$21.47M
Revenue Growth
+223.99%
P/S Ratio
2.18
Revenue / Employee
$294.16K
Employees
73
Market Cap
37.93M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.09M | 7.59M | 137.95% |
Dec 31, 2022 | 5.50M | 3.98M | 262.01% |
Dec 31, 2021 | 1.52M | -8.87M | -85.38% |
Dec 31, 2020 | 10.39M | 9.67M | 1,344.65% |
Dec 31, 2019 | 719.00K | -11.16M | -93.95% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionShield Therapeutics News
- 3 years ago - OTC Markets Group Welcomes Shield Therapeutics PLC to OTCQX - PRNewsWire